文献速递临床试验与 GCP真实世界研究与卫生经济

类风湿关节炎远程监测(REMORA):整合症状追踪干预的阶梯楔形整群随机试验及过程评估研究方案

Remote monitoring of rheumatoid arthritis (REMORA): study protocol for a stepped wedge cluster randomized trial and process evaluation of an integrated symptom tracking intervention.
PubMed 文献 · Trials · 2024-10-15

该研究为优势阶梯楔形整群随机对照试验,纳入16个风湿科门诊共732例活动性类风湿关节炎患者,比较常规诊疗与整合症状追踪(每日症状记录移动应用及电子病历交互式仪表盘)对疾病活动度的影响。主要结局为12±3个月时边际平均疾病活动度评分的差异,同时评估成本效果及实施过程。

要点

  • 整合症状追踪包括患者每日记录症状的移动应用和供医务人员查看的电子病历仪表盘。
  • 主要结局为12±3个月时两组边际平均疾病活动度评分的差异。
  • 试验同时进行过程评估以了解成功实施的因素。

核心结论

  • 该试验将产生整合症状追踪与常规诊疗相比的比较效果和成本效果的高质量证据,过程评估将提供成功实施的知识。
  • 若发现整合症状追踪具有(成本)效果,将优化其被更广泛采纳的机会。

研究设计与样本

  • 优势阶梯楔形整群随机对照试验,采用连续招募短暴露设计,16个风湿科门诊(整群)共招募732例活动性类风湿关节炎患者。
  • 各整群最初按标准诊疗提供门诊访视,随后以随机顺序每3周成对切换至整合症状追踪访视。
  • 整合症状追踪包括患者每日追踪症状及其他类风湿关节炎方面的移动应用,以及医务人员从电子病历系统访问的交互式仪表盘。

主要发现

  • 主要结局为12±3个月时标准诊疗与整合症状追踪之间边际平均疾病活动度评分的差异,分析时校正基线值、整群及其他协变量。
  • 次要结局包括患者报告的疾病活动度、生活质量及质量调整生命年、药物/资源使用、就诊与决策体验、自我管理及疾病感知。
  • 同时开展访谈和观察作为平行过程评估的一部分,以收集实施信息。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Management of rheumatoid arthritis (RA) relies on symptoms reported by patients during infrequent outpatient clinic visits. These reports are often incomplete and inaccurate due to poor recall, leading to suboptimal treatment decisions and outcomes. Asking people to track symptoms in-between visits and integrating the data into clinical pathways may improve this. However, knowledge on how to implement this into practice and its impact on services and outcomes remains scarce in RA. Therefore, we evaluate the comparative effectiveness and cost-effectiveness of integrated symptom tracking in people with RA over and above usual care, while generating insights on factors for successful implementation. METHODS: In this superiority stepped wedge cluster-randomized controlled trial with continuous recruitment short exposure design, 16 rheumatology outpatient departments (clusters) recruit a total of 732 people with active RA. They initially offer clinic visits according to standard of care before switching in pairs to visits with integrated symptom tracking. Clusters switch in randomized order every 3 weeks. Integrated symptom tracking consists of (1) a mobile app for patients to track their symptoms daily and other RA aspects weekly/monthly, and (2) an interactive dashboard visualizing the app data, which healthcare professionals access from their electronic health record system. Clinic visits happen according to usual practice, with tracked symptom data only reviewed during visits. Our primary outcome is a difference in marginal mean disease activity score at 12 ± 3 months between standard of care and integrated symptom tracking, after accounting for baseline values, cluster, and other covariates. Secondary outcomes include patient-reported disease activity, quality of life and quality-adjusted life-years, medication/resource use, consultation and decision-making experience, self-management, and illness perception. We also conduct interviews and observations as part of a parallel process evaluation to gather information on implementation. DISCUSSION: Our trial will generate high-quality evidence of comparative and cost-effectiveness of integrated symptom tracking compared to standard of care in people with RA, with our process evaluation delivering knowledge on successful implementation. This optimizes the chances of integrated symptom tracking being adopted more widely if we find it is (cost-) effective. TRIAL REGISTRATION: Registered 4-Jun-2024 on https://www.isrctn.com/ , ISRCTN51539448. TRIAL OPEN SCIENCE FRAMEWORK REPOSITORY: https://osf.io/sj9ha/ .

来源:Trials,查看原文。版权归原作者所有。

引用

  1. van der Veer SN, Griffiths-Jones D, Parkes M, et al. Remote monitoring of rheumatoid arthritis (REMORA): study protocol for a stepped wedge cluster randomized trial and process evaluation of an integrated symptom tracking intervention. Trials. 2024. PMID: 39407290. doi:10.1186/s13063-024-08497-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。